Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003653priorityCriticalpatent/ECSP003653A/en
Publication of ECSP003653ApublicationCriticalpatent/ECSP003653A/en
El presentei invento se refiere a una composición farmacéutica que comprende por lo menos un inhibidor de lipasas y por lo menos un éster de ácido graso de polioles, caracterizado porque el éster de ácido graso tiene un punto de fusión por encima de la temperatura corporal y los polioles se eligen del grupo constituido por glicerol, azúcares, derivados de azúcar y sus mezclas.The present invention relates to a pharmaceutical composition comprising at least one lipase inhibitor and at least one polyol fatty acid ester, characterized in that the fatty acid ester has a melting point above body temperature and Polyols are chosen from the group consisting of glycerol, sugars, sugar derivatives and mixtures thereof.
A SOLUTION THAT INCLUDES A PHARMACEUTICALLY ACTIVE AZAESTEROID AND A GLICEROL FATTY ACID ESTER OR PROPILES GLICOL, PHARMACEUTICAL COMPOSITIONS THAT COMPLETE THE GELATINE SOLUTION AND CAPSULES FILLED WITH THE PHARMACEUTICAL COMPOSITION.